Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Feb;27(1):45-58.
doi: 10.1023/a:1022639228723.

Inhibition of the neutrophil NADPH oxidase by adenosine is associated with increased movement of flavocytochrome b between subcellular fractions

Affiliations

Inhibition of the neutrophil NADPH oxidase by adenosine is associated with increased movement of flavocytochrome b between subcellular fractions

Steve D Swain et al. Inflammation. 2003 Feb.

Abstract

Adenosine is a potent inhibitor of reactive oxygen species (ROS) production by the NADPH oxidase in fMLF-stimulated neutrophils. Although much is known about the pharamacology and signal transduction of this effect, it is not known how adenosine affects assembly and localization of the NADPH oxidase components within the neutrophil. We report here that adenosine pretreatment of fMLF-stimulated neutrophils results in decreased plasma membrane/secretory granule content of the flavocytochrome b components (p22phox and gp91phox) of the NADPH oxidase, which correlates with inhibition of ROS production. Adenosine treatment did not affect upregulation of secretory and specific granule surface markers, confirming that degranulation was not impaired by adenosine. However, adenosine treatment did result in increased movement of cell-surface flavocytochrome b to heavy granule fractions in fMLF-stimulated neutrophils. These data suggest that adenosine-mediated effects on neutrophil ROS production are due, in part to endocytosis and/or redistribution of flavocytochrome b between various subcellular compartments.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Ann N Y Acad Sci. 1997 Dec 15;832:426-48 - PubMed
    1. J Leukoc Biol. 1992 Mar;51(3):270-5 - PubMed
    1. J Cell Biol. 1991 May;113(4):743-56 - PubMed
    1. Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3019-23 - PubMed
    1. Clin Exp Immunol. 1997 Aug;109(2):279-85 - PubMed

Publication types

MeSH terms

LinkOut - more resources